<!doctype html>

*|MC:SUBJECT|*

View this email in your browser
 
 

ASBMR Abstract Center is Open for Late-Breaking Research! Submissions Due Wednesday, June 5!

With the fast pace of modern biomedical research, ASBMR recognizes that late-breaking findings of broad and exceptional importance may occur after our initial abstract deadline has passed, and that conclusions and data from important clinical trials may not have been available.  In order to present the most current research in the bone, mineral and musculoskeletal field, ASBMR extends an invitation to scientists in all sectors to submit abstracts on clinical, basic and translational subjects that describe novel, groundbreaking research findings of the highest scientific impact. The deadline for late-breaking abstract submissions is Wednesday, June 5, 2019. Click here for more information!

 

Teaching a Course in Bone, Mineral or Musculoskeletal Science? Customize the ASBMR Primer for Your Course!

A new program from our publishing partner Wiley gives you the freedom to build your course materials exactly the way you want them and offer your students a cost-efficient alternative to traditional texts. Using Custom Select, you can use certain chapters in any order from the Ninth Edition of the ASBMR Primer, add new content from other textbooks, choose a cover template, select the format for the book, and then submit the project to production with the simple click of a button.
 
Want to know more? Visit the Wiley Custom Select site today, or check out a demo here.

 

Senate Aging Committee Report on Falls -
Stakeholder Request for Information

This year, the United States Senate Aging Committee will produce a report focused on the prevention and management of falls and fall-related injuries. Click here to read the letter from Chairman Collins and Ranking Member Casey inviting stakeholders to provide recommendations that will inform the Committee’s work. ASBMR members in the US are encouraged to respond as individuals or from their institutions. Please submit all written comments to the Special Committee on Aging via email at AnnualReport@aging.senate.gov. Feel free to provide introductory comments and background in your responses; however, in providing answers to the questions that most closely relate to your work, please reference which category and question you are answering specifically. The deadline for responses is Wednesday, June 26, 2019.

 

Register Today for the ASBMR Webinar:
“Anabolics and Combination Therapy”


Osteoporosis medications can be classified as either antiresorptive or anabolic based on their mechanism of action. In contrast to other chronic diseases such as hypertension or diabetes, osteoporosis therapy has generally been limited to the sequential administration of a standard dose of a single medication. More recently, however, the efficacy of several combined anabolic/antiresorptive approaches to osteoporosis have been evaluated in clinical trials. Moreover, as osteoporosis treatment options continue to expand, and clinical guidelines have begun to include the concept of limiting treatment courses to several years, defining the optimal use of multiple agents in sequence has also become an area of increasing interest. In this webinar, Benjamin Leder, M.D. will review the relative efficacy of the various approaches to combination osteoporosis therapy as well as the comparative skeletal effects of the various sequential approaches evaluated to date. This webinar will be held on Wednesday, June 5, 2019 at 12:00 PM EDT. Click here to learn more and register!
 

Register Today for the Thursday, May 30th Pre-Application Webinar for Dissemination and Implementation Research in Health Reissuance

This webinar will provide a brief overview and answer questions related to three NCI Funding Opportunity Announcements: Dissemination and Implementation Research in Health: PAR-19-274 R01: Clinical Trial Optional, PAR-19-275 R21: Clinical Trial Optional, and PAR-19-276 R03: Clinical Trial Not Allowed. The FOAs encourage investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. NCI staff will provide orientation and technical assistance by explaining the goals and objectives for the FOAs and answer questions from webinar attendees. Representatives from other co-signed NIH Institutes and Centers will be available to answer IC-specific questions. This webinar will be held on Thursday, May 30th at 3:00 PM EDT. Click here to register today!

 

Last Call to Join ASBMR’s National Osteoporosis Month
Awareness Campaign!


May is National Osteoporosis Month, and this week ASBMR members are sharing their stories on the theme of osteoporosis prevention. If you study osteoporosis or are involved in the care of patients at high risk of fracture, ASBMR wants to hear about it and share your story! Members are encouraged to fill out this short form between now and May 31, 2019, and ASBMR will share your stories via Facebook and Twitter. The goal of this campaign is to help increase public awareness of osteoporosis and highlight the scientific advances that our community has made in the research of osteoporosis to date. Please take a moment and share with the world why the work you do changes lives.
 

One More Week to Double Your Donation – ARE YOU IN?


This is a special time for the ASBMR Fund for Research and Education.  Not only is it National Osteoporosis Month, it’s a time to celebrate bone health and an opportunity to make a difference for those who will lead the bone, mineral and musculoskeletal field in the future. Thanks to the incredible generosity of our members, we have successfully raised over $3,000 thus far. BE IN and help us get to our goal of $5,000 raised for our early career investigators by the end of May! Watch the video above to learn directly from young investigators on the impact the ASBMR Fund for Research and Education has had on their careers.  And remember, every donation you give during the month of May will be matched dollar for dollar thanks to the ASBMR. Click here to make your donation today!
 
JBMR® Highlights
The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey
Qiang Zeng, Na Li, Qianqian Wang, Jian Feng, Dongmao Sun, Qiu Zhang, Jiyuan Huang, Qingxiang Wen, Rong Hu, Liang Wang, Yuanzheng Ma, Xiaoxia Fu, Shengyong Dong, Xiaoguang Cheng
First Published: 08 May 2019
 
Beclin1 modulates bone homeostasis by regulating osteoclast and chondrocyte differentiation
Atsushi Arai, Sol Kim, Vadim Goldshteyn, Terresa Kim, No‐Hee Park, Cun‐Yu Wang, Reuben Kim
First Published: 10 May 2019
 
VEGFA from Early Osteoblast Lineage Cells (Osterix+) is Required in Mice for Fracture Healing
Evan G. Buettmann, Jennifer A. McKenzie, Nicole Migotsky, David A.W. Sykes, Pei Hu, Susumu Yoneda, Matthew J. Silva
First Published: 13 May 2019
JBMR® Plus Highlights
The May issue is now online!
  • Discogenic Back Pain: Literature Review of Definition, Diagnosis, and Treatment
  • Combination Therapy With Zoledronic Acid and FES‐Row Training Mitigates Bone Loss in Paralyzed Legs
  • Effects of Whole‐Body Vibration Therapy on Distal Tibial Myotendinous Density and Volume
Microdamage as a Bone Quality Component: Practical Guidelines for the 2D Analysis of Linear Microcracks in Human Cortical Bone
Victoria M. Dominguez, Amanda M. Agnew
First Published: 13 May 2019
Bone Science in the News
Soy foods linked to fewer fractures in younger breast cancer survivors
Medical Xpress (5/21/2019)
 
Supreme Court sends dispute over Fosamax back to lower court
Seattlepi.com (5/20/2019)
 
New drug could alleviate symptoms of rare musculoskeletal condition
News-Medical.net (5/20/2019)
 
Medications associated with fracture risk in patients with rheumatoid arthritis
Annals of the Rheumatic Diseases (5/15/2019)
 
Record set for most osteoporosis screenings
Canadian Healthcare Technology (5/15/2019)
 
Tenex Health Announces 510(k) US FDA Clearance for TX®-Bone to Help Patients Restore Musculoskeletal Function Without Invasive Surgery
Daily Herald (5/13/2019)
 
FRAX data suggest no increased fracture risk with aromatase inhibitor use
Endocrine Today (5/13/2019)
 
Jefferson researcher discovers a population of bone cells that subdues cancer
News-Medical.net (5/13/2019)
Events Calendar
May 29 – June 1, 2019
Vitamin D Workshop
New York, NY, USA
 
May 30 – June 1, 2019
7th Seoul Symposium on Bone Health
Seoul, Republic of Korea
 
May 31 – June 1, 2019
Wisconsin Bone Club
Madison, WI, USA
 
June 6, 2019
NYU Center for Skeletal and Craniofacial Biology (CSCB) 2019 Symposium
New York, NY, USA
 
June 21, 2019
Symposium on Muscle-Bone Interaction in Duchenne Muscular Dystrophy 2019
Salzburg, Austria
Contact ASBMR
ASBMR Business Office
2025 M Street, NW
Suite 800
Washington, DC 20036-3309 USA
Tel.: +1 (202) 367-1161
Fax: +1 (202) 367-2161
Email: asbmr@asbmr.org


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list